コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n enteric infections, in both developing and industrialized countries.
2 common, accounting for 1-2% of all deaths in industrialized countries.
3 extent than that seen in clinical trials in industrialized countries.
4 is one of the most common causes of death in industrialized countries.
5 des with the obesity epidemic, especially in industrialized countries.
6 o of life, although uncommon, is observed in industrialized countries.
7 tents and market exclusivity periods in most industrialized countries.
8 nation affect up to 20% of the population in industrialized countries.
9 d as a diarrhoeal pathogen in developing and industrialized countries.
10 ause mortality effect of the pandemic for 21 industrialized countries.
11 part of monitoring HIV-infected patients in industrialized countries.
12 rrhea and endemic diarrhea in developing and industrialized countries.
13 Ulcerative colitis is most common in Western industrialized countries.
14 is a major cause of disability and death in industrialized countries.
15 most common gynecological cancer in Western industrialized countries.
16 ns the leading cause of skin cancer death in industrialized countries.
17 associated with measles eradication in seven industrialized countries.
18 r disease is the principal cause of death in industrialized countries.
19 s is a major cause of food-borne diseases in industrialized countries.
20 es of immune dysregulation are increasing in industrialized countries.
21 ere these conditions are more common than in industrialized countries.
22 th aging differs across social groups within industrialized countries.
23 rted recently in the United States and other industrialized countries.
24 (HEV) is endemic in many developing and some industrialized countries.
25 hich affects nearly 10% of the population in industrialized countries.
26 e is a major cause of nosocomial diarrhea in industrialized countries.
27 loping countries and is also endemic in many industrialized countries.
28 pically >/=100-fold higher than rates in the industrialized countries.
29 Allergic diseases have been increasing in industrialized countries.
30 most developing countries than in infants in industrialized countries.
31 historical experience with typhoid fever in industrialized countries.
32 Asthma has been increasing in industrialized countries.
33 ed copper from the typical diets consumed in industrialized countries.
34 ty, is also a major determinant of health in industrialized countries.
35 data set based on breast-fed infants in six industrialized countries.
36 esophageal/gastric cardia adenocarcinomas in industrialized countries.
37 become recognized as an emerging problem in industrialized countries.
38 ota of individuals in industrialized and non-industrialized countries.
39 comparing microbiota between low-income and industrialized countries.
40 solated from patients in both developing and industrialized countries.
41 sen sharply in recent decades, especially in industrialized countries.
42 tion compared to rural populations from less industrialized countries.
43 e prevalent in 1% to 3% of adults in Western industrialized countries.
44 cer mortality in the United States and other industrialized countries.
45 s (NASH) is the most common liver disease in industrialized countries.
46 hese diseases are increasing in frequency in industrialized countries.
47 sease, one of the leading causes of death in industrialized countries.
48 t common form of acute viral encephalitis in industrialized countries.
49 are largely based on the experience of a few industrialized countries.
50 is the most common chronic liver disorder in industrialized countries.
51 als has virtually eliminated human rabies in industrialized countries.
52 important airborne human fungal pathogen in industrialized countries.
53 d 2008 and is higher than that in many other industrialized countries.
54 sthma occur at higher rates in developed and industrialized countries.
55 count for nearly 10% of all cancer deaths in industrialized countries.
56 oping countries as well as sporadic cases in industrialized countries.
57 ge SCCP stocks are present in urban areas of industrialized countries.
58 loping countries and is also endemic in many industrialized countries.
59 has been observed with growing incidence in industrialized countries.
60 r cause of acute hepatitis in developing and industrialized countries.
61 asingly important cause of genital herpes in industrialized countries.
62 t leading cause of blindness in adulthood in industrialized countries.
63 f children and approximately 5% of adults in industrialized countries.
64 lergens constitute a major health problem in industrialized countries.
65 g world, and the indirect economic impact on industrialized countries.
66 roprevalences of 0.3%-53% were reported from industrialized countries.
67 se becomes necessary as has been the case in industrialized countries.
68 r spatial distribution highly skewed towards industrialized countries.
69 ent systems that have been widely adopted in industrialized countries.
70 now ubiquitous in the serum of residents of industrialized countries.
71 to 20% of children and 1% to 3% of adults in industrialized countries.
72 health problems with increasing incidence in industrialized countries.
73 prevalence of allergic diseases observed in industrialized countries.
74 aller geographical scale, especially in less industrialized countries.
75 us (HEV) infection is an emerging disease in industrialized countries.
76 e is the third most common cause of death in industrialized countries.
77 is the most frequent occupational disease in industrialized countries.
78 ts acquired from companion animals (cats) in industrialized countries.
79 times higher in developing countries than in industrialized countries (150/100,000 children/year vers
80 from repeated cross-sectional surveys of 10 industrialized countries (38 nationally representative t
81 apita carbon footprint of infrastructures in industrialized countries (53 (+/- 6) t CO2) was approxim
82 ls/d is the most common pattern of eating in industrialized countries, a scientific rationale for thi
83 t commonly diagnosed malignancy among men in industrialized countries, accounting for the second lead
84 lly causes diarrhea in humans, especially in industrialized countries, adapting a more host-restricte
86 lations in developing countries, children in industrialized countries also benefit from increasing kn
87 rs' diarrhea in visitors to these areas from industrialized countries, although the relative importan
88 gum is common in human gut microbiomes from industrialized countries and appears contingent on a sin
89 ountries: approximately 100-600 kg/capita in industrialized countries and below 100 kg/capita in deve
91 is the most lethal gynecologic malignancy in industrialized countries and has limited treatment optio
92 respective prevalence estimates obtained in industrialized countries and in selected less developed
93 s the most prevalent nutritional disorder in industrialized countries and is a growing problem in dev
94 (NAFLD) is the most common liver disease in industrialized countries and is increasing in prevalence
95 D) remains the leading cause of mortality in industrialized countries and is rapidly becoming a prima
96 the leading cause of childhood blindness in industrialized countries and is the fifth leading cause
97 nsion affects approximately 30% of adults in industrialized countries and is the major risk factor fo
98 the African meningitis belt is lower than in industrialized countries and is very diverse and dynamic
99 Prostate cancer is a very common disease in industrialized countries and it is known to be androgen-
101 (NAFLD) is the most common liver disease in industrialized countries and may proceed to steatohepati
102 due to RSV are higher than those reported in industrialized countries and similar to those reported i
104 the leading causes of blindness in adults in industrialized countries and the emerging cause of blind
105 ng proportion of iron-replete individuals in industrialized countries and the possible increased risk
106 CI], 20.1-70.3) per 1000 persons per year in industrialized countries and the seasonal incidence rate
108 he population of the United States and other industrialized countries and, at present, short of surgi
109 ewater treatment system (WWTS) located in an industrialized country and consisting of primary, second
110 why skill demands have persistently risen in industrialized countries, and considers the economic val
111 It is one of the most common diseases in industrialized countries, and in the United States accou
112 lar virology of HEV, mode of transmission in industrialized countries, and potential implications for
113 ancreatitis is 5 to 12 per 100 000 adults in industrialized countries, and the incidence is increasin
114 hods, a large percentage of children in many industrialized countries are being tested as a being at
117 ted in the increase of obesity and cancer in industrialized countries but are poorly understood.
118 cently, hepatitis E was rarely identified in industrialized countries, but Hepatitis E now is reporte
119 c diseases represent a significant burden in industrialized countries, but why and how the immune sys
120 conclusions drawn from research in affluent, industrialized countries can be applied globally; that a
122 n-6.9 million) of RSV-ARI in older adults in industrialized countries (data for developing countries
123 AD) remains the number one cause of death in industrialized countries despite our collective efforts
124 to well-oxygenated lacustrine conditions in industrialized countries despite the implementation of r
127 leading cause of morbidity and mortality in industrialized countries, especially in the elderly.
128 found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak o
129 e that focusing on loss and damage distracts industrialized countries from attempts to avoid losses a
130 our newfound relationship with nutrition in industrialized countries has fundamentally altered the w
131 Others argue that insufficient mitigation by industrialized countries has unleashed an unfair burden
132 and good quality health-care system, whereas industrialized countries have a major need for greater p
134 otech to developing nations, scientists from industrialized countries have the heightened responsibil
135 ies, mostly from the United States and other industrialized countries, have examined the associations
136 irus (HEV) infection can also be acquired in industrialized countries-HEV genotype 3 infection is a z
138 ubstantially in the past few decades in most industrialized countries; however, not all of the increa
139 ppendicitis or appendectomy is high in newly industrialized countries in Asia (South Korea pooled: 20
140 health risks, governments in developing and industrialized countries in Asia, Europe, Africa, and No
142 and drug use, depression and suicide in most industrialized countries in the decades following the Se
143 Asia and Africa and is also endemic in many industrialized countries, including the United States.
146 urden of allergic and autoimmune diseases in industrialized countries is inappropriate immune develop
149 as in other developing countries but unlike industrialized countries, is delivered as a 3-dose prima
150 diarrhea in the United States and many other industrialized countries, is recognized as a major healt
151 hough the disease has been declining in most industrialized countries, it remains the second most com
152 d sucrose and low in fiber, found rampant in industrialized countries, leads to worse disease and poo
153 istribution of POPs in densely populated and industrialized countries located in temperate regions.
155 sts that the resurgence of pertussis in many industrialized countries may result from the failure of
156 stic leukemia (ALL) are now over 80% in most industrialized countries, not all children have benefite
159 This data set, representative of an entire industrialized country, presents a reference point for c
160 prematurity and cardiopulmonary diseases in industrialized countries, primarily affect term infants
166 tis were higher than estimates reported from industrialized countries, such as Australia, New Zealand
167 ngly, the diseases of particular concern for industrialized countries--such as type 2 diabetes, obesi
168 tock saturates at 8-12 tons as evidence from industrialized countries suggests, consumption may peak
169 ong children <2 years of age, while those in industrialized countries tended to occur in older person
170 allergic conditions among children living in industrialized countries than those in developing region
171 EVIEW: There is something about living in an industrialized country that dramatically increases the r
172 ently, the United States is the only wealthy industrialized country that has not achieved universal h
174 rate is similar (approximately 10%) in most industrialized countries; the illness has a large econom
176 ection account for about 2% of all deaths in industrialized countries; they are also components of se
177 recommended strategy in a growing number of industrialized countries, to protect young infants from
179 termine prices for drugs, whereas most other industrialized countries use a variety of approaches to
180 of 2 populations from nonindustrialized and industrialized countries using identical methods and the
182 ome vaccines have proven highly effective in industrialized countries where the disease burden is low
183 appears to be an emerging problem in several industrialized countries, where it is mostly associated
184 ideration in women's health, particularly in industrialized countries, where the incidence of this tu
185 y increase the risk or severity of asthma in industrialized countries whereas vitamin A deficiency co
186 differ significantly between developing and industrialized countries, which calls into question the
187 bally, with generally a higher prevalence in industrialized countries, which may be explained by expo
189 to affect more than 30% of the population in industrialized countries with a still increasing inciden
195 door resolution was developed for Canada, an industrialized country with low air pollution levels, wh
196 tality is beyond the peacetime experience of industrialized countries, with a 5-year decline in life